Efficacy and Safety Testing

Author(s):  
J.W. Fluhr ◽  
M. Miteva ◽  
P. Elsner
2020 ◽  
Vol 17 (11-12) ◽  
pp. 827-841
Author(s):  
Chloe E Spencer ◽  
Lucy E Flint ◽  
Catherine J Duckett ◽  
Laura M Cole ◽  
Neil Cross ◽  
...  

2012 ◽  
Vol 91 (8) ◽  
pp. 2046-2054 ◽  
Author(s):  
A. Osselaere ◽  
M. Devreese ◽  
A. Watteyn ◽  
V. Vandenbroucke ◽  
J. Goossens ◽  
...  

2016 ◽  
Vol 27 (1) ◽  
pp. 13
Author(s):  
Mohak Mhatre

Human immunodeficiency virus (HIV) is transmitted predominantly through sexual intercourse. Research suggeststhat the vaginal epithelium acts as a barrier to HIV transmission, but this epithelium can be disrupted, leading toHIV infection and other sexually transmitted infections. Topical microbicides are considered an effective strategy forHIV prevention, and several candidate drugs are currently in clinical trials. However, significant concerns about drugadherence, efficacy, and safety must be addressed in order to develop a safe and effective microbicide. This paper willprovide an overview of the field and strategies to overcome some of the obstacles facing microbicide development,and briefly discuss a research project that focused on one aspect of preclinical microbicide safety testing.


Author(s):  
Yonghao Ma ◽  
Chengguo Li ◽  
Zhuoxian Mai ◽  
Jian Yang ◽  
Meiling Tai ◽  
...  

2008 ◽  
Vol 11 (4) ◽  
pp. 618-622 ◽  
Author(s):  
Saputera . ◽  
Djumali Mangunwidj ◽  
Sapta Raharja ◽  
Leonardus B.S. Kardono ◽  
Dyah Iswantini

2015 ◽  
Vol 44 (3) ◽  
pp. 346-357 ◽  
Author(s):  
Nikolai Klymiuk ◽  
Frank Seeliger ◽  
Mohammad Bohlooly-Y ◽  
Andreas Blutke ◽  
Daniel G. Rudmann ◽  
...  

2001 ◽  
Vol 120 (5) ◽  
pp. A572-A572
Author(s):  
F JABOLI ◽  
E RODA ◽  
C FABBRI ◽  
S MARCHETTO ◽  
F FERRARA ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document